Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 312353/Z/24/Z | Other Grant/Funding Number | Wellcome Trust |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut Pasteur | INDUSTRY |
| CDC - Ministry of Health of Cambodia | UNKNOWN |
| UMR ASTRE (CIRAD) | UNKNOWN |
| Malaria Consortium |
Not provided
Not provided
Not provided
Not provided
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies.
RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One Health approach. We will answer key questions on burden, ecology, transmission and population immune status to inform targeted and culturally appropriate interventions. The project combines a nationally representative One Health survey, social-science methods, and multiplex, diverse diagnostics to efficiently test for 57 priority pathogens, including zoonotic and vector-borne agents, vaccine-preventable and elimination-targeted diseases, enteric, respiratory, and environmentally transmitted pathogens and selected neglected tropical diseases and parasites relevant to Cambodia.
Mathematical modelling will reconstruct and forecast transmission dynamics and assess the potential impact of future public-health strategies. By integrating intersectoral data and innovative methods, RACSMEI will generate actionable evidence for public-health authorities, support precision One Health interventions, and help reduce disease burden in affected communities. The project also aims to ensure the transferability of methods and insights to other countries facing similar challenges.
RACSMEI is a nationwide, One Health, multi-pathogen initiative designed to generate integrated evidence for public-health decision-making in Cambodia. Beyond producing epidemiological findings, the project will establish a structured biobank and curated datasets intended to support long-term collaborative research, knowledge sharing, and evidence-informed policy. The program includes capacity building and technology transfer to strengthen national institutions and foster regional scientific leadership and international collaboration. Engagement with communities and national stakeholders is planned to facilitate future studies and promote the uptake of results in practice. Overall, RACSMEI aims to provide a scalable model for integrated infectious-disease assessment in low- and middle-income settings, creating durable infrastructure, partnerships, and decision-support resources that can be used beyond the project period.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Human Community Cohort (National Population Sample) | Probability-based, multi-stage population sample of ~10,000 participants (2-75 years old) recruited across urban and rural communities nationwide. Data include standardized questionnaires (demography, health conditions, mobility, animal contact, healthcare access) and serum biospecimens for multiplex serology; |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Seroprevalence of antibodies against an established panel of priority pathogens in the surveyed human populations: | The proportion of sampled individuals with detectable antibodies against this priority panel of pathogens, measured using multiplex serological assays. | At the time of blood sampling during household visits, over the inclusion period from December 2025 to April 2026. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study population comprises approximately 10,000 participants aged 2 to 75 years, drawn from 4,160 households across Cambodia's 25 provinces. Households will be randomly selected from 104 villages to ensure a nationally representative sample that reflects the country's diverse geographic and demographic characteristics. Participants will provide detailed socio-demographic information, enabling post-stratification weighted analysis of the sample's structure by sex, age, and geographic area to facilitate the extrapolation of findings to the entire population, ensuring that the study's conclusions are broadly applicable.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Claude Flamand, Ph.D. | Contact | +855012333650 | cflamand@pasteur-kh.org | |
| Najet Hadhri, MSc. | Contact | +34661400698 | nhadhri@pasteur-kh.org |
| Name | Affiliation | Role |
|---|---|---|
| Claude Flamand, Ph.D. | Institut Pasteur du Cambodge | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut Pasteur du Cambodge | Recruiting | Phnom Penh | Phnom Penh | 12201 | Cambodia |
Not provided
| Label | URL |
|---|---|
| Dedicated website page related to the study | View source |
| Wellcome Trust project description page | View source |
Not provided
Not provided
| OTHER |
| Ministry of Agriculture, Forestry and Fisheries Cambodia | UNKNOWN |
Not provided
Not provided
Not provided
Human serum aliquots derived from venous blood collected in dry tubes and stored at ≤-80 °C for multiplex serology. In selected workflows, pathogen nucleic acids may be generated for testing but are not retained.
Co-located animal specimens include sera (poultry, pigs, dogs, cattle, sheep/goats) and oral/rectal swabs; rodent specimens collected near households for laboratory testing. These samples are processed and archived according to standardized procedures. Environmental specimens retained include surface swabs, water samples (with 0.2 µm filtrates/membranes), air and soil samples from high-risk human-animal-environment interfaces. Vector collections (mosquito specimens obtained with BG-traps) are retained for entomological and pathogen investigations. All retained specimens are aliquoted as appropriate and stored in the IPC biobank under controlled temperatures for up to 15 years.
| ID | Term |
|---|---|
| D003715 | Dengue |
| D065632 | Chikungunya Fever |
| D000071243 | Zika Virus Infection |
| D004672 | Encephalitis, Japanese |
| D004675 | Encephalitis, Tick-Borne |
| D000085142 | Severe Fever with Thrombocytopenia Syndrome |
| D045464 | Henipavirus Infections |
| D018778 | Hantavirus Infections |
| D016751 | Hepatitis E |
| D002006 | Brucellosis |
| D011778 | Q Fever |
| D007922 | Leptospirosis |
| D008554 | Melioidosis |
| D008288 | Malaria |
| D015004 | Yellow Fever |
| D002044 | Bunyaviridae Infections |
| D012295 | Rift Valley Fever |
| D001117 | Arenaviridae Infections |
| D008457 | Measles |
| D009107 | Mumps |
| D012409 | Rubella |
| D012400 | Rotavirus Infections |
| D014917 | Whooping Cough |
| D013742 | Tetanus |
| D002644 | Chickenpox |
| D006506 | Hepatitis A |
| D017250 | Caliciviridae Infections |
| D004769 | Enterovirus Infections |
| D000257 | Adenoviridae Infections |
| D010322 | Parvoviridae Infections |
| D020031 | Epstein-Barr Virus Infections |
| D009175 | Mycoplasma Infections |
| D002690 | Chlamydia Infections |
| D004605 | Elephantiasis, Filarial |
| D005873 | Giardiasis |
| D007896 | Leishmaniasis |
| D014257 | Trichuriasis |
| D012552 | Schistosomiasis |
| D008581 | Meningitis |
| D003141 | Communicable Diseases |
| D000079426 | Vector Borne Diseases |
| D015047 | Zoonoses |
| D000079263 | Vaccine-Preventable Diseases |
| D058069 | Neglected Diseases |
| ID | Term |
|---|---|
| D000096724 | Mosquito-Borne Diseases |
| D007239 | Infections |
| D001102 | Arbovirus Infections |
| D014777 | Virus Diseases |
| D018177 | Flavivirus Infections |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D006482 | Hemorrhagic Fevers, Viral |
| D018354 | Alphavirus Infections |
| D014036 | Togaviridae Infections |
| D004671 | Encephalitis, Arbovirus |
| D018792 | Encephalitis, Viral |
| D020805 | Central Nervous System Viral Diseases |
| D002494 | Central Nervous System Infections |
| D000069544 | Infectious Encephalitis |
| D004660 | Encephalitis |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D000090862 | Neuroinflammatory Diseases |
| D017282 | Tick-Borne Diseases |
| D018184 | Paramyxoviridae Infections |
| D018701 | Mononegavirales Infections |
| D006525 | Hepatitis, Viral, Human |
| D006505 | Hepatitis |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D016905 | Gram-Negative Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D013145 | Spirochaetales Infections |
| D019121 | Burkholderia Infections |
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
| D006524 | Hepatitis, Viral, Animal |
| D006520 | Hepatitis, Animal |
| D000820 | Animal Diseases |
| D018185 | Morbillivirus Infections |
| D019351 | Rubulavirus Infections |
| D010309 | Parotitis |
| D010305 | Parotid Diseases |
| D012466 | Salivary Gland Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D018355 | Rubivirus Infections |
| D012088 | Reoviridae Infections |
| D001885 | Bordetella Infections |
| D012141 | Respiratory Tract Infections |
| D012140 | Respiratory Tract Diseases |
| D003015 | Clostridium Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D000073618 | Varicella Zoster Virus Infection |
| D006566 | Herpesviridae Infections |
| D004266 | DNA Virus Infections |
| D010850 | Picornaviridae Infections |
| D014412 | Tumor Virus Infections |
| D009180 | Mycoplasmatales Infections |
| D002694 | Chlamydiaceae Infections |
| D015231 | Sexually Transmitted Diseases, Bacterial |
| D012749 | Sexually Transmitted Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D005368 | Filariasis |
| D017205 | Spirurida Infections |
| D017190 | Secernentea Infections |
| D009349 | Nematode Infections |
| D006373 | Helminthiasis |
| D008209 | Lymphedema |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007411 | Intestinal Diseases, Parasitic |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D056986 | Euglenozoa Infections |
| D012876 | Skin Diseases, Parasitic |
| D012874 | Skin Diseases, Infectious |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D017189 | Enoplida Infections |
| D017188 | Adenophorea Infections |
| D014201 | Trematode Infections |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided